Research Article |
Corresponding author: Wamidh H. Talib ( altaei_wamidh@yahoo.com ) Academic editor: Danka Obreshkova
© 2024 Asma Ismail Mahmod, Muna Oqal, Ali Muharrif Khalid, Fatma U. Afifi, Wamidh H. Talib.
This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Citation:
Mahmod AI, Oqal M, Khalid AM, Afifi FU, Talib WH (2024) Phytochemical analysis, antioxidant, and antitumor activity of Ligustrum ovalifolium leaves grown in Jordan: an in vitro and in vivo study. Pharmacia 71: 1-10. https://doi.org/10.3897/pharmacia.71.e111517
|
Ligustrum ovalifolium (family Oleaceae) is a flowering plant with reported anti-inflammatory, antioxidant, hypotensive, and hypoglycemic activities. The present study investigated the phytochemical components and biological activities of L. ovalifolium leaves. Results showed that ethyl acetate extract has the highest potential to reduce cell growth in HeLa, T47D, and MDA-MB-231 cell lines with IC₅₀ values of 0.047, 0.07, and 0.072 mg/mL, respectively. Based on the LD50 value, the tumor-bearing mice were IP injected with 12.5 mg/kg of ethyl acetate extract. Tumor growth was significantly reduced (-43.1%) compared to the control group. According to the LC-MS analysis, Apigenin-7-O-glucoside was the flavonoid with the highest percentage value in L. ovalifolium leaves. DPPH assay exhibited antioxidant activity of ethanol and water extracts with the percentage of scavenging around 91% at a concentration of 200 µg/mL. As well, the assessment of liver and kidney functions of the experimented animals showed no toxicity effect compared to the control result. All things considered, the outcomes of this study revealed an antitumor potential of L. ovalifolium leaves extracts, hence this activity may arise from the presence of different potent flavonoids and the antioxidant potential. Nevertheless, further investigations are needed to determine the targets and signaling pathways that are affected by L. ovalifolium leaves extracts.
L. ovalifolium leaves, antitumor activity, LC-MS analysis, MTT assay, Apigenin-7-O-glucoside
For centuries, plants have been a rich source for the discovery of potent pharmacologically active compounds, used in the treatment of different diseases (
Ligustrum ovalifolium Hassk., known by the common names “Korean privet”, “California privet”, “garden privet”, or “oval-leaved privet”, belongs to the olive family Oleaceae (
The fresh leaves of the L. ovalifolium plant were collected from the campus of the Applied Science Private University (ASU) (Amman, Jordan) in March-April 2022. The taxonomic identity of the plant was authenticated by Prof. Fatma Afifi using herbarium samples and descriptive references. Herbarium samples are deposited in the Department of Pharmaceutical Chemistry and Pharmacognosy (ASU) (FMJ-OLE1).
Fresh leaves of L. ovalifolium were soaked separately in three solvents with different polarities (ethyl acetate, 70% ethanol, and water) and heated until boiling with continuous stirring (1:10 w/v). The extracts were covered and kept overnight at room temperature. After filtration, the solvents were evaporated using a rotary evaporator until dry. The obtained dried crude extracts were kept at -20 °C until use.
Total phenol content was determined according to Folin-Ciocalteu (F-C) method (
Total flavonoid content was investigated using the Aluminum chloride (AlCl3) method as described earlier (
To prepare the sample, ethyl acetate extract was dissolved in 2 mL dimethyl sulfoxide (DMSO) completing the volume up to 50 mL with acetonitrile solvent. At 4000 rpm, the sample was centrifuged for 2 min, followed by moving 1 mL to the autosampler (injection volume was 3 µL). The analysis was performed using Burker Daltonik (Berman, Germany) impact II ESI-Q-TOF system equipped with the Burker Dalotonik Elute UPLC system (Bremen, Germany) as described by Al-Mterin et al.(
The antioxidant potential of ethyl acetate, ethanol, and aqueous extracts of L. ovalifolium leaves was investigated according to the radical scavenging activity of the stable synthetic free radical 2, 2-diphenyl-1-picrylhydrazyl (DPPH) as demonstrated in the literature (
%I = (A° – Ax) / A° × 100 (1)
To investigate the antiproliferative activity of L. ovalifolium extracts, six cancer cell lines were used. Human breast cancer cells (T47D and MDA-MB-231), human colon cancer (Caco-2), human prostate cancer (PC3), human cervical cancer (HeLa), and non-cancerous fibroblast cells were provided from the University of Jordan. Mouse mammary sarcoma cells (EMP6/P) were purchased from the European Collection of Cell Cultures (Salisbury, UK). The cells were cultured in a complete medium and incubated in proper conditions, including 37 °C, 5% CO₂, and 95% humidity. The type of culture media varied according to the cell line. In particular, T47D and PC3 cell lines were cultured in a completed RPMI 1640 medium (PAN-biotech, Germany), while MDA-MB-231, Caco-2, HeLa, and fibroblast were cultured in a complete DMEM medium (PAN-biotech, Germany). As well, a completed MEM medium (PAN-biotech, Germany) was used for EMT6/P culturing. All types of media were supplemented with 10% heat-inactivated fetal bovine serum (Gibco, UK), 1% penicillin-streptomycin (Sigma, USA), 1% L-glutamine (Sigma, USA), and 0.1% gentamycin (EuroClone, Italy).
The cytotoxicity of L. ovalifolium leaves extracts was detected using MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) as described in the literature (
Percentage of cell viability (%) = (OD of treated cell/OD of control cell) × 100 (2)
The half-maximum inhibitory concentration (IC50) of the treated cells was determined using SPSS (Statistical Package for the Social Science, Illinois version 24).
The experiments with the animals were approved by the Research and Ethical Committee of Applied Science Private University (Approval Number: 2015-PHA-05). Thirty Balb/C female mice (4–6 weeks old, weight 21–25 g) were pathogen-free housed including convenient temperature (25 °C) and humidity of less than 60% in single cages, and had access to a standard pellet diet and water ad libitum before starting the experiments. The required conditions have been applied to keep the animals with ongoing air ventilation.
To determine the proper starting dose in the LD50 estimation assay, a limit test was performed. A small group of female mice (n=2) was treated (IP injection) with L. ovalifolium ethyl acetate extract. After 24 hrs, mortality incidence was observed. In case the mice have tolerated the dose, a gradual increase in the concentration (the dose multiplied by 1.5) is applied; otherwise, the dose will be reduced by 0.7. The maximum non-lethal and minimum lethal doses demonstrated the lower and upper limits, which were used to achieve the LD50 estimation assay (
LD50 estimation assay was carried out by treating (IP injection) three groups of mice (n=4) with three doses of ethyl acetate extract (100, 300, and 500 mg/kg). All the investigated doses were within the upper and lower range that was recognized in the limit test. The vital conditions of the treated mice were observed for 24 hrs. The arithmetical method of Karber was considered to estimate the LD50 of L. ovalifolium leaves (
EMT6/P cells were collected and prepared to be inoculated in Balb/C mice (n=18) with a density of 1 × 106 cells/0.1 mL via subcutaneous injection. After 10 days, the size of the growing tumors was measured using a digital caliper (Vogel, Germany). Tumor-bearing mice were divided into a control group (n=9) (with no treatment) and a treatment group (n=9) (treated with ethyl acetate extract). In particular, ethyl acetate extract was prepared for IP injection in a concentration of 12.5 mg/kg which is 10% of the estimated LD50 value. The treatment stage was carried on for 10 days and during that tumor measurement was reported and serum samples were collected for further analysis. At the end of the experiment, the mice were sacrificed using cervical dislocation method and all the tumors were extracted and kept in 10% formalin. The volumes of the tumors were calculated according to the following equation (3) (
Volumes of the tumors = A × B2 × 0.5 (3)
Whereas (A) = the length of the longest aspect of the tumor, (B) = the length of the perpendicular to A
Creatinine was measured to evaluate nephrotoxicity. Alanine transaminase (ALT) and aspartate transaminase (AST) were evaluated to assess liver function. Quantification of these biomarkers was achieved by following the protocol of specific kits including ALAT (GPT) FS* (Cat. No. 1 2701 99 10 972, Holzheim, Germany), ASAT (GOT) FS* (Cat. No. 1 2601 99 10 021, Holzheim, Germany), and Creatinine FS* (Cat. No. 1 1711 99 10 021, Holzheim, Germany) using DiaSys Respons 920 analyzer (Holzheim, Germany).
Data was demonstrated using the mean ± SEM (Standard Error of Mean). The statistical significance between groups was detected utilizing SPSS student’s t-test. Variation between groups was approved significantly when the p-value is less than 0.05 (p < 0.05). IC50 values were determined by applying non-linear regression in SPSS (Statistical Package for the Social Science, Chicago, Illinois version 24).
Despite all technological advancements in cancer prevention and treatment, cancer is still one of the main causes of death around the world (
Source | Extraction solvent | % of dried extracts yield |
---|---|---|
Ligustrum ovalifolium leaves | Ethyl acetate | 3.73% |
Ethanol | 12.14% | |
Water | 17.24% |
Based on MTT results, ethyl acetate inhibited tumor cell growth at a low concentration of around 40 to 70 µg/mL particularly in cervical and breast cancer cell lines (Table
IC50 values of L. ovalifolium extracts against different cancer cell lines.
T47D | MDA-MB-231 | PC3 | Caco-2 | HeLa | EMT6/P | Fibroblast | |
---|---|---|---|---|---|---|---|
IC50 | IC50 | IC50 | IC50 | IC50 | IC50 | IC50 | |
(mg/mL)±SEM | (mg/mL)±SEM | (mg/mL)±SEM | (mg/mL)±SEM | (mg/mL)±SEM | (mg/mL)±SEM | (mg/mL)±SEM | |
Ethyl acetate extract | 0.07±0.08 | 0.072±0.03 | 0.17±0.02 | 0.16±0.06 | 0.047±0.08 | 0.21±0.05 | >5 |
Ethanol extract | 0.87±0.12 | 0.74±0.14 | 0.57±0.03 | 1.2±0.12 | 0.87±0.16 | 1.8±0.03 | >5 |
Aqueous extract | >5 | 1.88±0.1 | 0.70±0.09 | 1.53±0.12 | 2.22±0.09 | 1.8±0.16 | >5 |
As well, ethanol and aqueous extracts were able to reduce the percentage of survival in both PC3 and MDA-MB-231 cell lines (Fig.
The antiproliferative activity of L. ovalifolium extracts against (A) T47D cell line (B) MDA-MB-231 cell line (C) HeLa cell line (D) Caco-2 cell line (E) PC3 cell line (F) EMT6/P cell line (G) Fibroblast cell line. Results are expressed as means of three independent experiments (bars) ± SEM (lines).
Based on the limit test result, the non-lethal dose of ethyl acetate extract IP injection was 100 mg/kg. By following the arithmetical method of Karber, the estimated LD50 of ethyl acetate extract was 125 mg/kg (Table
Groups (n=4) | Dose (mg/kg) | No. of mortality | Dose difference (a) | Mean mortality (b) | Probit (a × b) |
---|---|---|---|---|---|
1 | 100 | 0 | 0 | 0 | 0 |
2 | 300 | 2 | 200 | 1 | 200 |
3 | 500 | 3 | 200 | 2.5 | 500 |
In the animal model experiment, Ethyl acetate extract was selected for the in vivo assay since it exhibited the best antiproliferative efficacy in the in vitro assessment among the three extracts. After treating tumor-bearing mice (n=9) with L. ovalifolium ethyl acetate extract (12.5mg/kg), results revealed a -43.1% reduction in tumor size compared to the negative control (48.1%) (Table
Antitumor effect of L. ovalifolium ethyl acetate extract in the animal model.
Treatment groups (n=9) | Initial tumor size (mm³) ± SEM | Final tumor size (mm³) ± SEM | % Change in tumor size | % of mice with no detectable tumor | Number of death | Average tumor weight (mg) |
---|---|---|---|---|---|---|
Control group | 332.2±15 | 492.2±11 | 48.1 | 11.1 | 1 | 512.8 |
Ligustrum ovalifolium group | 367.3±22 | 208.7±16 | -43.1 | 55.1 | 0 | 228.2 |
In the present study, the antiproliferative efficacy of the ethylacetate extract of L. ovalifolium leaves is for the first time demonstrated while for some other species of the genus Ligustrum, cytotoxic effects against different cancer cells were reported. A recent study revealed the antiproliferative activity of different phytochemicals isolated from L. japonicum fruits (
NO | Compounds | RT (Retention time) | Formula | Relative % (ethyl acetate extract) |
---|---|---|---|---|
1 | 2,4-Dihydroxyacetophenone | 5.41 | C8H8O3 | 0.130681 |
2 | Luteolin 7-O-glucoside (Cynaroside) | 5.88 | C21H20O11 | 15.84325 |
3 | Isorhoifolin | 6.54 | C27H30O14 | 7.621954 |
4 | Apigenin-7-O-glucoside (Apigetrin) | 6.77 | C21H20O10 | 34.6314 |
5 | 7-Glu Chrysoeriol (NMR) | 7.11 | C22H22O11 | 2.079451 |
6 | Luteolin | 8.57 | C15H10O6 | 19.05762 |
7 | Tiliroside | 8.8 | C30H26O13 | 0.139487 |
8 | Oct-1-en-3-yl Ara (1-6)Glu (NMR) | 8.9 | C19H34O10 | 0.344667 |
9 | naringenin | 9.53 | C15H12O5 | 0.104087 |
10 | Baicalein | 9.86 | C15H10O5 | 19.7901 |
11 | Madecassic acid | 15.56 | C30H48O6 | 0.090174 |
12 | Hederagenin | 21.62 | C30H48O4 | 0.084362 |
13 | Ursolic acid | 27.19 | C30H48O3 | 0.082776 |
Additionally, ethyl acetate extract revealed the highest phenol content (154.7 mg GAE/g), and flavonoids (100.3 mg RE/g) as well as a high value of IC50 (33 µg/mL) according to DPPH assay (Table
Total phenol, flavonoid content, and antioxidant activity of L. ovalifolium.
L. ovalifolium leaves extracts | TFC* (mg RE/g) | TPC* (mg GAE/g) | DPPH assay IC50 (µg/mL) |
---|---|---|---|
Ethyl acetate extract | 100.3±0.4 | 154.7±0.4 | 33±9.2 |
Ethanol extract | 41.5±0.1 | 115.2±1.1 | 46.7±11 |
Aqueous extract | 22.6±0.3 | 87.9±0.1 | 52.2±8.6 |
Ascorbic acid | 1.74±0.2 |
The natural flavonoid apigenin-7-O-glucoside with multiple biological activities has high stability and good solubility (
There is a correlation between the antioxidant effect of plant extracts and their cytotoxic activity. Reactive oxygen species (ROS) can stimulate DNA damage which may lead to converting normal cells into cancerous ones by genetic mutation (
To evaluate the effect of L. ovalifolium leaves treatment on the main functional biomarkers of the liver and kidney in mice; serum samples for both, treated and untreated groups of animals were analyzed. There are slight differences between the ethyl acetate group and the control group, which indicate the safety of the L. ovalifolium leaves extract with no toxic effects on kidney and liver functions (Table
The results of this study suggested that L. ovalifolium leaves extracts could be considered a promising medicinal plant with anticancer potential. Ethyl acetate extract of L. ovalifolium leaves exhibited high potency in preventing cell growth of various cancer types as well as reduced tumor size and enhanced quick recovery of mice bearing breast cancer. Besides, the phytochemical analysis revealed the richness of the active ethyl acetate extract in flavonoids, which are recognized by their antioxidant and antiproliferative activities. Nevertheless, further investigations are needed to determine the targets and signaling pathways that are affected by L. ovalifolium extracts.
Ligustrum ovalifolium leaves ethyl acetate extract LCMS results
Data type: docx
Explanation note: Spectra of identified compunds in Ligustrum ovalifolium extraxts using LCMS